AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 14th, there was short interest totaling 417,214 shares, an increase of ? from the July 30th total of 0 shares. Based on an average daily trading volume, of 1,423,228 shares, the short-interest ratio is currently 0.3 days.
AXIM Biotechnologies Price Performance
AXIM opened at $0.00 on Friday. AXIM Biotechnologies has a twelve month low of $0.00 and a twelve month high of $0.03.
AXIM Biotechnologies Company Profile
AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.
The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.
Featured Stories
- Five stocks we like better than AXIM Biotechnologies
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
